Next Article in Journal
Role of Flex-Dose Delivery Program in Patients Affected by HCC: Advantages in Management of Tare in Our Experience
Previous Article in Journal
Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn’s Disease: A Review of Comparative Effectiveness Studies
 
 
Case Report

Article Versions Notes

J. Clin. Med. 2024, 13(8), 2189; https://doi.org/10.3390/jcm13082189
Action Date Notes Link
article xml file uploaded 10 April 2024 12:05 CEST Original file -
article xml uploaded. 10 April 2024 12:05 CEST Update https://www.mdpi.com/2077-0383/13/8/2189/xml
article pdf uploaded. 10 April 2024 12:05 CEST Version of Record https://www.mdpi.com/2077-0383/13/8/2189/pdf
article html file updated 10 April 2024 12:06 CEST Original file https://www.mdpi.com/2077-0383/13/8/2189/html
Back to TopTop